DE:OMA Stock Latest News
Company AnnouncementsVivesto Receives U.S. Orphan Drug Designation for Cantrixil in AML20m ago
Company AnnouncementsVivesto boosts Paccal Vet’s global profile with new oncology data at WSAVA 20263w ago
Company AnnouncementsVivesto’s Paccal Vet Data Spotlighted at Key Veterinary Oncology Conference1M ago
Company AnnouncementsVivesto’s Paccal Vet Shows Promising Efficacy and Safety in Feline Cancer Study1M ago
Company AnnouncementsVivesto’s Paccal Vet Shows Survival Benefit in Canine Hemangiosarcoma Study1M ago
Company AnnouncementsVivesto Sets Maximum Tolerated Dose in Feline Paccal Vet Cancer Study4M agoCompany AnnouncementsVivesto completes dog cancer trial recruitment as Paccal Vet nears key data readout4M ago
Company AnnouncementsVivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data4M ago
Company AnnouncementsVivesto’s Cantrixil Clears Key Preclinical Hurdle With Positive i.v. Safety Data4M ago
Company AnnouncementsVivesto names seasoned life science financier Björn Svanström as new CFO5M ago
Company AnnouncementsVivesto Cuts Share Count After 1-for-100 Reverse Split5M ago